Axsome Therapeutics (AXSM) Operating Income Growth (5y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.87% |
| Dec 31, 2025 | 41.40% |
| Sep 30, 2025 | -16.89% |
| Jun 30, 2025 | -15.61% |
| Mar 31, 2025 | -11.89% |
| Dec 31, 2024 | -24.35% |
| Sep 30, 2024 | -27.01% |
| Jun 30, 2024 | -42.15% |
| Mar 31, 2024 | -45.21% |
| Dec 31, 2023 | -65.45% |
| Sep 30, 2023 | -49.77% |
| Jun 30, 2023 | -52.11% |
| Mar 31, 2023 | 2.31% |
| Dec 31, 2022 | -62.41% |
| Sep 30, 2022 | -54.26% |
| Jun 30, 2022 | -50.82% |
| Mar 31, 2022 | -47.54% |
| Dec 31, 2021 | -44.39% |
| Sep 30, 2021 | -46.00% |
| Jun 30, 2021 | -45.49% |
| Mar 31, 2021 | -46.43% |
| Dec 31, 2020 | -60.93% |
| Sep 30, 2020 | -65.56% |
| Jun 30, 2020 | -60.13% |
| Mar 31, 2020 | -79.83% |